SCHEMBL6170341

SCHEMBL6170341

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)C(C)CC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.59
ALDH1A1 P00352 8/20 0.55
LMNA P02545 4/20 0.55
KDM4E B2RXH2 3/20 0.55
RAB9A P51151 4/20 0.55
MAPT P10636 3/20 0.55
NPC1 O15118 2/20 0.55
PKM P14618 1/20 0.55
CRHBP P24387 1/20 0.55
CRHR2 Q13324 1/20 0.55
POLB P06746 2/20 0.54
PTGER4 P35408 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.48
GAA P10253 1/20 0.48
MEN1 O00255 2/20 0.47
HPGD P15428 2/20 0.46
GALR2 O43603 1/20 0.46
MITF O75030 1/20 0.46
HSP90AA1 P07900 1/20 0.46
XBP1 P17861 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168979 0.89 KMT2A (0.57) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL6172436 0.85 KMT2A (0.50) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL6170000 0.84 KMT2A (0.57) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL6169182 0.84 KMT2A (0.81) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL6172633 0.84 KMT2A (0.49) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL6168615 0.84 POLB (0.54) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL6170373 0.83 KMT2A (0.64) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL6169030 0.82 KMT2A (0.52) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL2248072 0.81 KMT2A (0.64) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL8890463 0.81 KMT2A (0.76) KMT2AALDH1A1LMNAKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed